Abbvie (($ABBV)) announced an update on their ongoing clinical study. Study Overview: AbbVie is conducting a multicenter, open-label study titled ...
TipRanks on MSN
Alto Neuroscience’s ALTO-100 Study: A Potential Game-Changer for Bipolar Disorder Treatment?
Alto Neuroscience, Inc. (($ANRO)) announced an update on their ongoing clinical study. Alto Neuroscience, Inc. is conducting a study titled ‘A ...
Results that may be inaccessible to you are currently showing.
Hide inaccessible results
Feedback